Federal Register / Vol. 62, No. 34 / Thursday, February 20, 1997 / Notices 7787

the agreement and proposed order, or to

modify in any way their terms.

Donald S. Clark,

Secretary.

[FR Doc. 97–4146 Filed 2–19–97; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary; Findings of

Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made a final finding of scientific

misconduct in the following case:

James B. Boone, Jr., Ph.D., University

of Missouri-Columbia: Based upon an

investigation conducted by the

University of Missouri-Columbia,

information obtained by the Office of

Research Integrity (ORI) during its

oversight review, and Dr. Boone’s own

admission, ORI found that Dr. Boone,

former Research Assistant Professor,

Department of Veterinary Biomedical

Sciences at the University of MissouriColumbia, engaged in scientific

misconduct by fabricating and falsifying

data in biomedical research supported

by a grant from the National Heart,

Lung, and Blood Institute (NHLBI),

National Institutes of Health (NIH).

Specifically, Dr. Boone fabricated the

weights of individual, isolated muscles

that, in fact, had not been separated by

dissection, and falsely presented

unrelated gamma counter results as

having been obtained from the same

individual muscles. He presented these

data to his laboratory director as the

results from two experiments that Dr.

Boone admitted he did not complete.

Dr. Boone committed additional

falsifications in conducting research,

including presenting: (1) A computer

spread sheet that used the above

described sets of the fabricated primary

data of muscle weights and the falsified

gamma counter results to generate false

computations of blood flow in separate

muscles; (2) A computer spread sheet

for the statistical computations of the

data from the two sets of fabricated and

falsified reduced data; and (3) A

histogram derived from the falsified

reduced data that showed significant

differences in some of the fabricated

experimental measurements on

individual muscles.

Dr. Boone has accepted the ORI

finding and has entered into a Voluntary

Exclusion Agreement with ORI in which

he has voluntarily agreed, for the three

(3) year period beginning February 10,

1997:

(1) To exclude himself from serving in

any advisory capacity to the Public

Health Service (PHS), including but not

limited to service on any PHS advisory

committee, board, and/or peer review

committee, or as a consultant; and

(2) That any institution that submits

an application for PHS support for a

research project on which the

respondent’s participation is proposed

or which uses the respondent in any

capacity on PHS supported research

must concurrently submit a plan for

supervision of his duties. The

supervisory plan must be designed to

ensure the scientific integrity of the

respondent’s research contribution. The

institution must submit a copy of the

supervisory plan to ORI.

No scientific publications were

required to be corrected as part of this

Agreement.

FOR FURTHER INFORMATION CONTACT:

Acting Director, Division of Research

Investigations Office of Research

Integrity, 5515 Security Lane, Suite 700,

Rockville, MD 20852, (301) 443–5330.

Chris B. Pascal,

Acting Director, Office of Research Integrity.

[FR Doc. 97–4081 Filed 2–19–97; 8:45 am]

BILLING CODE 4160–17–P

Centers for Disease Control and

Prevention

State Childhood Lead Poisoning

Prevention Grantees Meeting

The National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC) announces the

following meeting.

NAME: Meeting of State Childhood Lead

Poisoning Prevention Grantees.

TIMES AND DATES: 12 p.m.–4:10 p.m.,

February 24, 1997. 8:30 a.m.–5:30 p.m.,

February 25, 1997. 8 a.m.–5:10 p.m.,

February 26, 1997. 8:30 a.m.–11:40 a.m.,

February 27, 1997.

PLACE: Holiday Inn Select-AtlantaDecatur Hotel and Conference Plaza,

130 Clairemont Avenue, Decatur,

Georgia 30030, telephone 404/371–

0204.

STATUS: Open to the public, limited only

by space available. The meeting room

accommodates approximately 80

people.

PURPOSE: This meeting will provide a

forum for childhood lead poisoning

prevention coordinators and data

administrators to review program

progress and discuss prevention issues

and concerns. Persons wishing to make

written or oral comments at the meeting

should notify the contact person listed

below, in writing or by phone, no later

than close of business February 21,

1997.

Requests to make oral comments

should contain the name, address,

telephone number, and organizational

affiliation of the presenter. Depending

on the time available and the number of

requests to make oral comments, it may

be necessary to limit the time of each

presenter.

MATTERS TO BE DISCUSSED: Topics to be

discussed at this meeting include CDC’s

proposed revised screening guidelines,

establishment of a data system to

implement screening guidance, and data

recommendations. There will be

information presented regarding

computer programming and how it

relates to data analysis and using data

to make decisions. Agenda items are

subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION:

Claudette Grant, Lead Poisoning

Prevention Branch, Division of

Environmental Hazards and Health

Effects, NCEH, CDC, 4770 Buford

Highway, NE, M/S F42, Atlanta, Georgia

30341, telephone 770/488–7330, fax

770/488–7335.

Dated: February 13, 1997.

Joseph E. Salter,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–4139 Filed 2–19–97; 8:45 am]

BILLING CODE 4163–18–P

Administration for Children and

Families

Office of Planning, Research and

Evaluation; Statement of Organization,

Functions, and Delegations of

Authority

This Notice amends Part K, Chapter K

of the Statement of Organization,

Functions, and Delegations of Authority

of the Department of Health and Human

Services (DHHS), Administration for

Children and Families (ACF) as follows:

Chapter KM, The Office of Planning,

Research and Evaluation (OPRE) (60 FR

56606) as last amended, November 9,

1995. This reorganization will establish

the Division of Data Collection and

Analysis within the Office of Planning,

Research and Evaluation.

Amend Chapter KM as follows:

1. Delete KM.00 Mission in its

entirety and replace with the following:

KM.00 Mission. The Office of

Planning, Research and Evaluation

(OPRE) is the principal advisor to the

Deputy Assistant Secretary for Policy